Loda, Massimo

The landscape of somatic copy-number alteration across human cancers

Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature

Cancer Genomics and DiagnosticsGenomic variations and chromosomal abnormalities

Cited by 4,017

Integrative Clinical Genomics of Advanced Prostate Cancer

Robinson, D., Van Allen, E. M., Wu, Y.-M., Schultz, N., Lonigro, R. J., Mosquera, J.-M., Montgomery, B., Taplin, M.-E., Pritchard, C. C., Attard, G., et al. (2015) · Cell

Prostate Cancer Treatment and ResearchCancer Genomics and Diagnostics

Cited by 3,645

Targeting potential drivers of COVID-19: Neutrophil extracellular traps

Barnes, B. J., Adrover, J. M., Baxter-Stoltzfus, A., Borczuk, A., Cools-Lartigue, J., Crawford, J. M., Daßler-Plenker, J., Guerci, P., Huynh, C., Knight, J. S., et al. (2020) · Journal of Experimental Medicine

Neutrophil, Myeloperoxidase and Oxidative MechanismsCOVID-19 Clinical Research Studies

Cited by 1,486

Genomic correlates of clinical outcome in advanced prostate cancer

Abida, W., Cyrta, J., Heller, G., Prandi, D., Armenia, J., Coleman, I., Cieslik, M., Benelli, M., Robinson, D., Van Allen, E. M., et al. (2019) · Proceedings of the National Academy of Sciences

Prostate Cancer Treatment and ResearchChromatin Remodeling and Cancer

Cited by 1,372

mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways

Majumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine

PI3K/AKT/mTOR signaling in cancerCancer, Hypoxia, and Metabolism

Cited by 964

Inappropriate expression of hepcidin is associated with iron refractory anemia: implications for the anemia of chronic disease

Weinstein, D. A., Roy, C. N., Fleming, M. D., Loda, M. F., Wolfsdorf, J. I., & Andrews, N. C. (2002) · Blood

Iron Metabolism and DisordersErythropoietin and Anemia Treatment

Cited by 632

The histone methyltransferase SETDB1 is recurrently amplified in melanoma and accelerates its onset

Ceol, C. J., Houvras, Y., Jane-Valbuena, J., Bilodeau, S., Orlando, D. A., Battisti, V., Fritsch, L., Lin, W. M., Hollmann, T. J., Ferré, F., et al. (2011) · Nature

Melanoma and MAPK PathwaysZebrafish Biomedical Research Applications

Cited by 542

The androgen receptor cistrome is extensively reprogrammed in human prostate tumorigenesis

Pomerantz, M. M., Li, F., Takeda, D. Y., Lenci, R., Chonkar, A., Chabot, M., Cejas, P., Vazquez, F., Cook, J., Shivdasani, R. A., et al. (2015) · Nature Genetics

Prostate Cancer Treatment and ResearchChromatin Remodeling and Cancer

Cited by 470

Identification of the miR-106b ~ 25 MicroRNA Cluster as a Proto-Oncogenic PTEN -Targeting Intron That Cooperates with Its Host Gene MCM7 in Transformation

Poliseno, L., Salmena, L., Riccardi, L., Fornari, A., Song, M. S., Hobbs, R. M., Sportoletti, P., Varmeh, S., Egia, A., Fedele, G., et al. (2010) · Science Signaling

MicroRNA in disease regulationCancer-related molecular mechanisms research

Cited by 410

Federated benchmarking of medical artificial intelligence with MedPerf

Karargyris, A., Umeton, R., Sheller, M. J., Aristizabal, A., George, J., Wuest, A., Pati, S., Kassem, H., Zenk, M., Baid, U., et al. (2023) · Nature Machine Intelligence

Artificial Intelligence in Healthcare and EducationPrivacy-Preserving Technologies in Data

Cited by 188

A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer

Ahearn, T. U., Pettersson, A., Ebot, E. M., Gerke, T., Graff, R. E., Morais, C. L., Hicks, J. L., Wilson, K. M., Rider, J. R., Sesso, H. D., et al. (2015) · Journal of the National Cancer Institute

Prostate Cancer Treatment and ResearchProstate Cancer Diagnosis and Treatment

Cited by 186

Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer

Blume-Jensen, P., Berman, D. M., Rimm, D. L., Shipitsin, M., Putzi, M., Nifong, T. P., Small, C., Choudhury, S., Capela, T., Coupal, L., et al. (2015) · Clinical Cancer Research

Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and Research

Cited by 179

High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program

Labbé, D. P., Zadra, G., Yang, M., Reyes, J. M., Lin, C. Y., Cacciatore, S., Ebot, E. M., Creech, A. L., Giunchi, F., Fiorentino, M., et al. (2019) · Nature Communications

Cancer, Lipids, and MetabolismProstate Cancer Treatment and Research

Cited by 174

Androgen mediated regulation and functional implications of FKBP51 expression in prostate cancer

FEBBO, P. G., LOWENBERG, M., THORNER, A. R., BROWN, M., LODA, M., & GOLUB, T. R. (2005) · Journal of Urology

Prostate Cancer Treatment and ResearchSperm and Testicular Function

Cited by 99

Adipose Triglyceride Lipase Is a Therapeutic Target in Advanced Prostate Cancer That Promotes Metabolic Plasticity

Awad, D., Cao, P. H. A., Pulliam, T. L., Spradlin, M., Subramani, E., Tellman, T. V., Ribeiro, C. F., Muzzioli, R., Jewell, B. E., Pakula, H., et al. (2024) · Cancer Research

Cancer, Lipids, and MetabolismLipid metabolism and biosynthesis

Cited by 36

Metformin Overcomes the Consequences of NKX3.1 Loss to Suppress Prostate Cancer Progression

Papachristodoulou, A., Heidegger, I., Virk, R. K., Di Bernardo, M., Kim, J. Y., Laplaca, C., Picech, F., Schäfer, G., De Castro, G. J., Hibshoosh, H., et al. (2024) · European Urology

Metabolism, Diabetes, and CancerProstate Cancer Treatment and Research

Cited by 18

COVID-19 viral and serology testing in New York city health care workers

Racine-Brzostek, S. E., Yang, H. S., Chadburn, A., Orlander, D., An, A., Campion, T. R., Yee, J., Chen, Z., Loda, M., Zhao, Z., et al. (2020) · American Journal of Clinical Pathology

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testing

Cited by 12